Matches in SemOpenAlex for { <https://semopenalex.org/work/W1750541493> ?p ?o ?g. }
- W1750541493 endingPage "11291" @default.
- W1750541493 startingPage "11281" @default.
- W1750541493 abstract "After ischemic stroke, various damage-associated molecules are released from the ischemic core and diffuse to the ischemic penumbra, activating microglia and promoting proinflammatory responses that may cause damage to the local tissue. Here we demonstrate using in vivo and in vitro models that, during sublethal ischemia, local neurons rapidly produce interleukin-4 (IL-4), a cytokine with potent anti-inflammatory properties. One such anti-inflammatory property includes its ability to polarize macrophages away from a proinflammatory M1 phenotype to a healing M2 phenotype. Using an IL-4 reporter mouse, we demonstrated that IL-4 expression was induced preferentially in neurons in the ischemic penumbra but not in the ischemic core or in brain regions that were spared from ischemia. When added to cultured microglia, IL-4 was able to induce expression of genes typifying the M2 phenotype and peroxisome proliferator activated receptor γ (PPARγ) activation. IL-4 also enhanced expression of the IL-4 receptor on microglia, facilitating a feedforward increase in (1) their expression of trophic factors and (2) PPARγ-dependent phagocytosis of apoptotic neurons. Parenteral administration of IL-4 resulted in augmented brain expression of M2- and PPARγ-related genes. Furthermore, IL-4 and PPARγ agonist administration improved functional recovery in a clinically relevant mouse stroke model, even if administered 24 h after the onset of ischemia. We propose that IL-4 is secreted by ischemic neurons as an endogenous defense mechanism, playing a vital role in the regulation of brain cleanup and repair after stroke. Modulation of IL-4 and its associated pathways could represent a potential target for ischemic stroke treatment.Depending on the activation signal, microglia/macrophages (MΦ) can behave as healing (M2) or harmful (M1). In response to ischemia, damaged/necrotic brain cells discharge factors that polarize MΦ to a M1-like phenotype. This polarization emerges early after stroke and persists for days to weeks, driving secondary brain injury via proinflammatory mediators and oxidative damage. Our study demonstrates that, to offset this M1-like polarization process, sublethally ischemic neurons may instead secrete a potent M2 polarizing cytokine, interleukin-4 (IL-4). In the presence of IL-4 (including when IL-4 is administered exogenously), MΦ become more effective in the cleanup of ischemic debris and produce trophic factors that may promote brain repair. We propose that IL-4 could represent a potential target for ischemic stroke treatment/recovery." @default.
- W1750541493 created "2016-06-24" @default.
- W1750541493 creator A5006216095 @default.
- W1750541493 creator A5013488261 @default.
- W1750541493 creator A5029373305 @default.
- W1750541493 creator A5037746635 @default.
- W1750541493 creator A5060060979 @default.
- W1750541493 creator A5073501391 @default.
- W1750541493 date "2015-08-12" @default.
- W1750541493 modified "2023-10-17" @default.
- W1750541493 title "Neuronal Interleukin-4 as a Modulator of Microglial Pathways and Ischemic Brain Damage" @default.
- W1750541493 cites W1534334215 @default.
- W1750541493 cites W1574784740 @default.
- W1750541493 cites W1602738654 @default.
- W1750541493 cites W1742979798 @default.
- W1750541493 cites W1861582625 @default.
- W1750541493 cites W1991210089 @default.
- W1750541493 cites W1994535293 @default.
- W1750541493 cites W1994749115 @default.
- W1750541493 cites W1997132511 @default.
- W1750541493 cites W2003080204 @default.
- W1750541493 cites W2004733912 @default.
- W1750541493 cites W2011783556 @default.
- W1750541493 cites W2018895076 @default.
- W1750541493 cites W2023820705 @default.
- W1750541493 cites W2025080281 @default.
- W1750541493 cites W2028365642 @default.
- W1750541493 cites W2028450632 @default.
- W1750541493 cites W2030024131 @default.
- W1750541493 cites W2031692952 @default.
- W1750541493 cites W2035221144 @default.
- W1750541493 cites W2036192402 @default.
- W1750541493 cites W2039095220 @default.
- W1750541493 cites W2039304257 @default.
- W1750541493 cites W2042433863 @default.
- W1750541493 cites W2042690181 @default.
- W1750541493 cites W2044056372 @default.
- W1750541493 cites W2052551969 @default.
- W1750541493 cites W2053670331 @default.
- W1750541493 cites W2054113452 @default.
- W1750541493 cites W2057885957 @default.
- W1750541493 cites W2060157715 @default.
- W1750541493 cites W2060659287 @default.
- W1750541493 cites W2060668038 @default.
- W1750541493 cites W2064438985 @default.
- W1750541493 cites W2067500883 @default.
- W1750541493 cites W2070627442 @default.
- W1750541493 cites W2070855360 @default.
- W1750541493 cites W2076013123 @default.
- W1750541493 cites W2079209433 @default.
- W1750541493 cites W2089263724 @default.
- W1750541493 cites W2091142824 @default.
- W1750541493 cites W2095400574 @default.
- W1750541493 cites W2097756768 @default.
- W1750541493 cites W2098622411 @default.
- W1750541493 cites W2103125300 @default.
- W1750541493 cites W2105156168 @default.
- W1750541493 cites W2118200665 @default.
- W1750541493 cites W2127056008 @default.
- W1750541493 cites W2128627731 @default.
- W1750541493 cites W2134828784 @default.
- W1750541493 cites W2135340773 @default.
- W1750541493 cites W2137399557 @default.
- W1750541493 cites W2144132732 @default.
- W1750541493 cites W2144613271 @default.
- W1750541493 cites W2148641326 @default.
- W1750541493 cites W2149671708 @default.
- W1750541493 cites W2165553751 @default.
- W1750541493 cites W2169434098 @default.
- W1750541493 cites W2288947171 @default.
- W1750541493 cites W2462768047 @default.
- W1750541493 doi "https://doi.org/10.1523/jneurosci.1685-15.2015" @default.
- W1750541493 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4532758" @default.
- W1750541493 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26269636" @default.
- W1750541493 hasPublicationYear "2015" @default.
- W1750541493 type Work @default.
- W1750541493 sameAs 1750541493 @default.
- W1750541493 citedByCount "212" @default.
- W1750541493 countsByYear W17505414932016 @default.
- W1750541493 countsByYear W17505414932017 @default.
- W1750541493 countsByYear W17505414932018 @default.
- W1750541493 countsByYear W17505414932019 @default.
- W1750541493 countsByYear W17505414932020 @default.
- W1750541493 countsByYear W17505414932021 @default.
- W1750541493 countsByYear W17505414932022 @default.
- W1750541493 countsByYear W17505414932023 @default.
- W1750541493 crossrefType "journal-article" @default.
- W1750541493 hasAuthorship W1750541493A5006216095 @default.
- W1750541493 hasAuthorship W1750541493A5013488261 @default.
- W1750541493 hasAuthorship W1750541493A5029373305 @default.
- W1750541493 hasAuthorship W1750541493A5037746635 @default.
- W1750541493 hasAuthorship W1750541493A5060060979 @default.
- W1750541493 hasAuthorship W1750541493A5073501391 @default.
- W1750541493 hasBestOaLocation W17505414931 @default.
- W1750541493 hasConcept C126322002 @default.
- W1750541493 hasConcept C164027704 @default.
- W1750541493 hasConcept C169760540 @default.
- W1750541493 hasConcept C170493617 @default.